Results 91 to 100 of about 177,775 (151)

Endogenous retroviruses and response to immune checkpoint inhibitors: mechanisms, clinical evidence, and therapeutic implications. [PDF]

Front Immunol
Wu F, Danzeng Q, Wu R, Shen Y, Shi G.
europepmc   +1 more source

Synergistic immunomodulation: integrating physical ablation with immune checkpoint inhibitors for metastatic colorectal carcinoma. [PDF]

Front Immunol
Shi X, Wu C, Deng W.
europepmc   +1 more source

A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors. [PDF]

Front Immunol
Bertucci A, Taleb K, Billon E, Fernez T, Rochigneux P.   +4 more
europepmc   +1 more source

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors. [PDF]

Br J Haematol
Argnani L, Stefoni V, Casadei B, Pelusi C, Preiato VL, Pagotto U, Buganè A, Pellegrini C, Broccoli A, Zinzani PL.   +9 more
europepmc   +1 more source

Hemophagocytic Lymphohistiocytosis Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of Spontaneous Reports. [PDF]

Cancers (Basel)
Guzel SS, Tay K, Cicek E, Jeral Evinc S, Atak S, Papila C, Demirci NS, Alan O.   +7 more
europepmc   +1 more source

Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities. [PDF]

Front Immunol
Wen H, Qi Y, Song J, Yan X.
europepmc   +1 more source

Cardiotoxicity in dual immune checkpoint inhibitors: a critical appraisal of signal interpretation and future directions. [PDF]

Eur Heart J Cardiovasc Pharmacother
Dong W, Song Q, Wang Q.
europepmc   +1 more source

Acetaminophen interactions with immune checkpoint inhibitors: guilt by association? [PDF]

J Immunother Cancer
de Lemos ML, de Lemos J, Kletas V, Latt R, Mucovic J.   +4 more
europepmc   +1 more source